Karp JE - Search Results

1

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

Gojo I, Karp JE. Gojo I, et al. Among authors: karp je. Clin Cancer Res. 2014 Dec 15;20(24):6233-41. doi: 10.1158/1078-0432.CCR-14-0900. Epub 2014 Oct 16. Clin Cancer Res. 2014. PMID: 25324141 Free PMC article. Review.

2

Topoisomerase II levels during granulocytic maturation in vitro and in vivo.

Kaufmann SH, McLaughlin SJ, Kastan MB, Liu LF, Karp JE, Burke PJ. Kaufmann SH, et al. Among authors: karp je. Cancer Res. 1991 Jul 1;51(13):3534-43. Cancer Res. 1991. PMID: 1647269

3

Management of infectious complications of acute leukemia and antileukemia therapy.

Karp JE, Merz WG, Dick JD, Saral R, Burke PJ. Karp JE, et al. Oncology (Williston Park). 1990 Jul;4(7):45-53; discussion 53-4. Oncology (Williston Park). 1990. PMID: 2143941 Review.

4

Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

Rowinsky EK, Burke PJ, Karp JE, Tucker RW, Ettinger DS, Donehower RC. Rowinsky EK, et al. Among authors: karp je. Cancer Res. 1989 Aug 15;49(16):4640-7. Cancer Res. 1989. PMID: 2568175

5

Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy.

Geller RB, Boone LB, Karp JE, Davidson N, Selonick SE, Edwards J, Burke PJ. Geller RB, et al. Among authors: karp je. Cancer. 1989 Aug 1;64(3):629-34. doi: 10.1002/1097-0142(19890801)64:3<629::aid-cncr2820640311>3.0.co;2-l. Cancer. 1989. PMID: 2743258

6

In vivo cell growth and pharmacologic determinants of clinical response in acute myelogenous leukemia.

Karp JE, Donehower RC, Enterline JP, Dole GB, Fox MG, Burke PJ. Karp JE, et al. Blood. 1989 Jan;73(1):24-30. Blood. 1989. PMID: 2910362 Free article.

7

Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA.

Roubenoff R, Jones RJ, Karp JE, Stevens MB. Roubenoff R, et al. Among authors: karp je. Arthritis Rheum. 1987 Oct;30(10):1187-90. doi: 10.1002/art.1780301017. Arthritis Rheum. 1987. PMID: 3479115

8

Favorable outcome of invasive aspergillosis in patients with acute leukemia.

Burch PA, Karp JE, Merz WG, Kuhlman JE, Fishman EK. Burch PA, et al. Among authors: karp je. J Clin Oncol. 1987 Dec;5(12):1985-93. doi: 10.1200/JCO.1987.5.12.1985. J Clin Oncol. 1987. PMID: 3681380

9

Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia.

Kaufmann SH, Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ. Kaufmann SH, et al. Among authors: karp je. Blood. 1994 Jan 15;83(2):517-30. Blood. 1994. PMID: 7904487 Free article.

10

Therapy-related acute leukemia.

Karp JE, Sarkodee-Adoo CB. Karp JE, et al. Clin Lab Med. 2000 Mar;20(1):71-81, ix. Clin Lab Med. 2000. PMID: 10702897 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters